PA
RYAM icon

PharVision Advisers’s Rayonier Advanced Materials RYAM Stock Holding History

PharVision Advisers’s Portfolio RYAM Stock Details RYAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-27,523
Closed -$227K – 483
2024
Q4 		$227K Buy
+27,523
New +$232K 0.19% 249

Other funds holding RYAM

CM
Condire Management Dallas, Texas $1.03B AUM 162.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

PharVision Advisers's RYAM Position: Q1 2025 in Review

PharVision Advisers sold out of Rayonier Advanced Materials (RYAM) in Q1 2025, closing a stake of 27,523 shares — an estimated $227K sold.

PharVision Advisers first reported a position in RYAM in Q4 2024 and held it in 1 quarter. The position peaked at $227K in Q4 2024. 181 funds tracked by Wall St. Rank hold RYAM as of Q1 2025.

  • PharVision Advisers reported no remaining Rayonier Advanced Materials position as of Q1 2025 after selling out during the quarter.
  • PharVision Advisers sold 27,523 Rayonier Advanced Materials shares in Q1 2025, an estimated $227K.
  • PharVision Advisers first reported a position in Rayonier Advanced Materials in Q4 2024 and held it in 1 quarter.
  • PharVision Advisers's Rayonier Advanced Materials position peaked at $227K in Q4 2024.
  • 181 funds tracked by Wall St. Rank held Rayonier Advanced Materials as of Q1 2025.

Based on PharVision Advisers's 13F filing for Q1 2025, filed 15 May 2025.